Skip to content

The effect of isoflurane on postoperative gut microbiota and POD in elderly patients

The effect of isoflurane on postoperative gut microbiota and POD in elderly patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107864
Enrollment
Unknown
Registered
2025-08-20
Start date
2025-03-11
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium

Interventions

Experimental group (Diflurane group):Desflurane
Control group (sevoflurane group):Sevoflurane

Sponsors

First Affiliated Hospital of Gannan Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 60 years old, gender not limited; 2.Patients who plan to undergo unilateral or bilateral total hip replacement surgery for the first time under general anesthesia, with no contraindications related to surgery or anesthesia; 3.Anesthesia method: inhalation anesthesia with halothane or sevoflurane; 4.Baseline cognitive function: preoperative Mini Mental State Examination (MMSE) score, illiterate>17 points; Primary school score>20 points; Junior high school and above score>24 points; 5.ASA anesthesia grade I-III; 6.The patient or their legal representative understands and signs the informed consent form, and is willing to cooperate in completing the postoperative follow-up examination;

Exclusion criteria

Exclusion criteria: 1.History of mental and neurological disorders: Suffering from schizophrenia, moderate to severe depression, Parkinson's disease, epilepsy with seizure records within the past year, and other diseases; 2.History of intestinal diseases: Previous history of inflammatory bowel disease, intestinal tumors, intestinal obstruction, intestinal diverticulitis, etc; 3.History of drug allergies: Allergies to isoflurane, sevoflurane, or routine medications during and after surgery; 4.Severe impairment of liver and kidney function: liver function indicators exceeding the upper limit of normal by more than twice, or kidney function indicators reaching stage 3 or above of chronic kidney disease; 5.Other major diseases: severe cardiovascular disease, uncontrolled diabetes, advanced malignant tumor, etc.

Design outcomes

Primary

MeasureTime frame
Postoperative delirium incidence rate;Abundance of gut microbiota;Metabolites of gut microbiota;

Secondary

MeasureTime frame
Restlessness;Sleep quality;Local cerebral oxygen saturation; Heart rate, pulse oxygen saturation, systolic blood pressure, diastolic blood pressure, mean arterial pressure, etc;Preoperative MMSE score;Severity of delirium;

Countries

China

Contacts

Public ContactWeidong Liang

First Affiliated Hospital of Gannan Medical University

lwd0929@gmu.edu.cn+86 797 8689034

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026